Huaijun Zhu

1.1k total citations
60 papers, 772 citations indexed

About

Huaijun Zhu is a scholar working on Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Huaijun Zhu has authored 60 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Pharmacology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Huaijun Zhu's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Kidney Stones and Urolithiasis Treatments (6 papers). Huaijun Zhu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Kidney Stones and Urolithiasis Treatments (6 papers). Huaijun Zhu collaborates with scholars based in China, United States and Macao. Huaijun Zhu's co-authors include Weihong Ge, Li Yang, Naping Tang, Limei Yang, Feng Yu, Rihong Cong, Yun Fang, Qingmin Sun, Haijuan Gu and Bo Zhou and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, The Journal of Urology and Journal of Lipid Research.

In The Last Decade

Huaijun Zhu

58 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaijun Zhu China 16 197 115 113 100 99 60 772
Xiao‐cong Zuo China 16 130 0.7× 137 1.2× 99 0.9× 82 0.8× 81 0.8× 59 929
SoJeong Yi South Korea 18 130 0.7× 115 1.0× 157 1.4× 68 0.7× 110 1.1× 45 705
Chengxian Guo China 18 237 1.2× 61 0.5× 132 1.2× 80 0.8× 171 1.7× 76 804
Sumío Hirata Japan 15 115 0.6× 95 0.8× 68 0.6× 77 0.8× 83 0.8× 59 657
Kristin D. Marciante United States 15 145 0.7× 62 0.5× 194 1.7× 101 1.0× 115 1.2× 17 766
Masayuki Hashiguchi Japan 16 151 0.8× 74 0.6× 100 0.9× 110 1.1× 96 1.0× 64 936
Chandrahas Sahajwalla United States 14 151 0.8× 169 1.5× 100 0.9× 76 0.8× 88 0.9× 44 771
Sang‐Goo Shin South Korea 20 170 0.9× 130 1.1× 222 2.0× 111 1.1× 200 2.0× 43 911
Sooyoung Shin South Korea 16 223 1.1× 48 0.4× 63 0.6× 134 1.3× 119 1.2× 58 947
Christian Laveille France 14 120 0.6× 176 1.5× 102 0.9× 117 1.2× 117 1.2× 33 1.0k

Countries citing papers authored by Huaijun Zhu

Since Specialization
Citations

This map shows the geographic impact of Huaijun Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaijun Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaijun Zhu more than expected).

Fields of papers citing papers by Huaijun Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaijun Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaijun Zhu. The network helps show where Huaijun Zhu may publish in the future.

Co-authorship network of co-authors of Huaijun Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Huaijun Zhu. A scholar is included among the top collaborators of Huaijun Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaijun Zhu. Huaijun Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Min, Shuhan Zhang, Jun He, et al.. (2024). Biochemical classification diagnosis of polycystic ovary syndrome based on serum steroid hormones. The Journal of Steroid Biochemistry and Molecular Biology. 245. 106626–106626. 3 indexed citations
2.
Bian, Xiu‐Wu, Ting Yang, Shiming Jiang, et al.. (2024). 1959O BL-B01D1, an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic urothelial carcinoma (UC). Annals of Oncology. 35. S1133–S1133. 9 indexed citations
3.
Huang, Siqi, Min Wang, Xuemei Luo, et al.. (2023). Mid‐dosing interval concentration is important for polymyxin B exposure and acute kidney injury in critically ill patients. CPT Pharmacometrics & Systems Pharmacology. 12(12). 1911–1921. 2 indexed citations
4.
Zheng, Xinxin, et al.. (2023). Effect of Tacrolimus Time in Therapeutic Range on Postoperative Recurrence in Patients Undergoing Liver Transplantation for Liver Cancer. Therapeutic Drug Monitoring. 46(1). 42–48. 4 indexed citations
5.
Yang, Na, Ji Cheng, Jiajia Ge, et al.. (2023). Metabolic alteration of circulating steroid hormones in women with gestational diabetes mellitus and the related risk factors. Frontiers in Endocrinology. 14. 1196935–1196935. 8 indexed citations
6.
7.
8.
Zhang, Tianqi, Siqi Huang, Min Wang, Na Yang, & Huaijun Zhu. (2023). Integrated untargeted and targeted proteomics to unveil plasma prognostic markers for patients with acute paraquat poisoning: A pilot study. Food and Chemical Toxicology. 182. 114187–114187. 2 indexed citations
9.
Wang, Min, Jie Xu, Na Yang, et al.. (2022). Insight Into the Metabolomic Characteristics of Post-Transplant Diabetes Mellitus by the Integrated LC-MS and GC-MS Approach- Preliminary Study. Frontiers in Endocrinology. 12. 807318–807318. 9 indexed citations
10.
Zhang, Tianqi, Huaijun Zhu, Min Wang, et al.. (2022). Serum proteomics analysis of biomarkers for evaluating clinical response to MTX/IGU therapy in early rheumatoid arthritis. Molecular Immunology. 153. 119–125. 1 indexed citations
11.
12.
Shi, Jian, Xinwen Wang, Huaijun Zhu, et al.. (2018). Determining Allele-Specific Protein Expression (ASPE) Using a Novel Quantitative Concatamer Based Proteomics Method. Journal of Proteome Research. 17(10). 3606–3612. 14 indexed citations
13.
Zhang, Yifan, et al.. (2016). Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review. International Urology and Nephrology. 48(7). 1061–1069. 7 indexed citations
14.
Zhu, Huaijun. (2011). Systematic assessment on randomized controlled trials for treatment of acute exacerbation of chronic obstructive pulmonary disease by tanreqing injection. 1 indexed citations
15.
Sun, Xizhao, et al.. (2011). Infrared spectroscopic analysis of 5,248 urinary stones from Chinese patients presenting with the first stone episode. Urological Research. 39(5). 339–343. 28 indexed citations
16.
Zhu, Huaijun. (2010). Systematic Review of Simple Oral Chinese Herbal Treatment for Acute Gouty Arthritis. Pharmacy Today. 1 indexed citations
17.
Zhu, Huaijun. (2009). The association between the survivin C-31G polymorphism and gastric cancer risk in Chinese population. 2 indexed citations
18.
Yang, Li, Huaijun Zhu, Bo Zhou, et al.. (2008). The Association Between the Survivin C-31G Polymorphism and Gastric Cancer Risk in a Chinese Population. Digestive Diseases and Sciences. 54(5). 1021–1028. 38 indexed citations
19.
Tang, Naping, Lian‐Sheng Wang, Li Yang, et al.. (2008). Genetic variant in glutathione peroxidase 1 gene is associated with an increased risk of coronary artery disease in a Chinese population. Clinica Chimica Acta. 395(1-2). 89–93. 43 indexed citations
20.
Tang, Naping, Liansheng Wang, Yang Li, et al.. (2007). A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease. Clinical Chemistry and Laboratory Medicine (CCLM). 45(11). 1471–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao‐cong Zuo Breakdown of academic impact, for papers by SoJeong Yi Breakdown of academic impact, for papers by Chengxian Guo Breakdown of academic impact, for papers by Sumío Hirata Breakdown of academic impact, for papers by Kristin D. Marciante Breakdown of academic impact, for papers by Masayuki Hashiguchi Breakdown of academic impact, for papers by Chandrahas Sahajwalla Breakdown of academic impact, for papers by Sang‐Goo Shin Breakdown of academic impact, for papers by Sooyoung Shin Breakdown of academic impact, for papers by Christian Laveille
Rankless by CCL
2026